Key takeaways
Levetiracetam (Keppra) and brivaracetam (Briviact) are both antiepileptic medications used to treat seizures, but they have some differences. Levetiracetam is available in both generic and brand forms, while brivaracetam is only available as the brand Briviact. Levetiracetam can be taken as an immediate-release tablet, extended-release tablet, or liquid, and is usually taken once or twice a day. Brivaracetam, on the other hand, is typically taken twice daily and comes as a tablet, oral solution, and injection. Levetiracetam is not a controlled substance, whereas brivaracetam is a Schedule V controlled substance, meaning it has some potential for abuse and dependence. Common side effects of levetiracetam include sleepiness, weakness, and headaches, while brivaracetam often causes drowsiness and dizziness.
